NExT for BHMS! Mandatory for Students Joining Internship After November 29

New Delhi: Introducing standardization in Homoeopathy education as well, the National Exit Test (NExT) has also been mandatory for the Bachelor of Homoeopathic Medicine and Surgery (BHMS) courses.

In this regard, the National Commission for Homoeopathy (National Examinations in Homoeopathy) Regulations, 2023 were published in the official Gazette of India on 22.11.2023 and the e-Gazette on 29.11.2023

Releasing a recent notice dated 14.12.2023, the National Commission for Homoeopathy has clarified that it is mandatory for the BHMS interns who have joined the internship on or after 29.11.2023 to appear in the National Exit Test.

“Qualifying of National Exit Test Examination and getting registered in a State or National Register shall be the essential requirement for practicing as a registered medical practitioner or for any job where clinical work is involved or for any job where medical registration is mandatory or to pursue post graduate programs in Homoeopathy,” mentioned the new regulations.

It was stated in the regulations that the NExT exam for the Homoeopathy courses shall ordinarily be conducted in the months of February and August every year.

While the NExT exam for Homoeopathy shall be held for granting license to practice as medical practitioner of Homoeopathy and for enrollment in the State or National Register, it is not going to replace the postgraduate entrance test for Homoeopathy courses.

As per the Regulations, the PG entrance test for Homoeopathy, All India Ayush Post-Graduate Entrance Test, shall be conducted by the National Commission for Homoeopathy every year in April or on the date specified by the Commission.

The National Commission for Homoeopathy (National Examinations in Homoeopathy) Regulations, 2023 were introduced by the National Commission for Homoeopathy, in exercise of the powers conferred by sub-section (1) and Clauses (h), (j), (k), (l), (m) and (n) of sub-section (2) of section 55 of the National Commission for Homoeopathy Act, 2020 (15 of 2020). “They shall come into force on the date of their publication in the Official Gazette,” mentioned the regulations.

National Exit Test:

The new regulations mentioned that a common National Exit Test for Homoeopathy shall be conducted by the Commission through designated authority as provided under sub section (1) of section 15 of the Act.

It further added that the NExT exam for Homoeopathy shall be held for granting license to practice as medical practitioner of Homoeopathy and for enrollment in the State Register or National Register as a registered medical practitioner of Homoeopathy.

Pattern of Examination: 

The pattern of the examination shall be problem based to test the clinical competency of a graduate of Homoeopathy as a registered medical practitioner in Homoeopathy, mentioned the Regulations.

Time-schedule for the Examination: 

As per the new NCH Regulations 2023, the National Exit Test examination for Homoeopathy shall be conducted ordinarily in the month of February and August every year.

Eligibility Criteria: 

Eligibility for appearing in the National Exit Test shall be as below:

(a) An intern who has completed minimum two hundred and seventy days of the internship by the last date for submission of application for the National Exit Test examination

(b) Graduates of Homoeopathy who have completed their internship

(c) Foreign Nationals whose medical qualification has been recognised in schedule III of Homoeopathy Central Council Act 1973 or Recognised as per section 36 of National Commission for Homoeopathy Act 2020. 

“However, the National Exit Test qualified candidates shall be eligible to get registered as medical practitioner only after completion of remaining duration of rotatory internship and fulfillment of criteria as specified by Board of Ethics and Registration for Homoeopathy,” clarified the Commission.

Who will Appear in NExT for Homoeopathy: 

In the Gazette notification, it was mentioned that the practitioners who have already been registered or have completed internship before the notification of the NCH Regulation 2023, need not appear for the NExT exam.

However, the Commission issued another notification on 14.12.2023 and mentioned, “…it is further to clarify that students who have joined internship before the date of publication of the above regulation in the gazette, need not appear in the National Exit Test. However, it is mandatory for interns who have joined internship on or after 29/11/2023 to appear in National Exit Test.”

“All State Registration Councils are hereby informed to continue registering eligible candidates accordingly if they have completed or joined their internship before 29/11/2023, and come to them for registration after completion of internship,” added the notification. 

“Date and other relevant details of the first National Exit Test shall be announced as per regulation and well in time,” the notice issued by NCH President Dr. Tarkeshwar Jain further mentioned.

Meanwhile, the newly notified regulations clarified that “As per sub-section (1) of section 15 of the National Commission for Homoeopathy Act 2020 (15 of 2020), without qualifying National Exit Test, no Homoeopathic graduate (Bachelor of Homoeopathic Medicine and Surgery) shall be eligible to get registered in the State or Union territory Administration or National register, as the case may be.”

The regulations further made it clear that “There shall not be any limit for attempts and duration to appear for National Exit Test” and “The candidates securing 50% and above shall be declared as qualified in National Exit Test Examination and the list of qualified candidates shall be displayed on the website of National Commission for Homoeopathy.”

What happens if a Candidate does not Clear NExT? 

In this regard, the new regulations mentioned that if a candidate does not clear the National Exit Test, his graduation degree shall be considered for all other job opportunities and other educational programs or courses where medical registration is not mandatory.

Explanation: Unlike all other graduation degree holders, this degree holder of Homoeopathy, who has not cleared the National Exit Test Examination shall not be eligible for medical practice, though they can appear for the jobs or post-graduation courses other than the post-graduate courses recognised by the Commission, where these degrees are recognised.

Apart from NExT for Homoeopathy, the newly notified regulations also discussed in detail the function and composition of the examination cell, duties and responsibilities of the controller and deputy controller of the examination, the details of the common advisory committee and technical committee, composition of the advisory committee, the terms of references of the advisory committee, composition and the terms of references of the technical committee, National Eligibility-cum-Entrance Test for Homoeopathy, All India Ayush Post Graduate Entrance Test, and National Teacher’s Eligibility Test.

To view the NCH Notification, click on the link below:

https://medicaldialogues.in/pdf_upload/nch-notification-229002.pdf

Also Read: NExT now mandatory after BAMS, BSMS, BUMS courses

Powered by WPeMatico

AIIMS Deoghar Releases Timetable For 1st Profesional MBBS Supplementary Exams 2022 Batch

Jharkhand: All
India Institute of Medical Sciences (AIIMS Deoghar) has released the timetable for the 1st professional MBBS supplementary examination 2022 batch.

The exams
are starting from 03-02-2024 and continue till 17-02-2024. The theory exams
will be conducted from 03-02-2024 to 14-02-2024, and practical exams will be
conducted from 15-02-2024 to 17-02-2024.

Detailed
schedule –

Theory –

Venue – Examination Hall, 2nd Floor, Academic Building, AIIMS, Deoghar.

DATE

DAY

TIME

SUBJECT

03-02-2024

Saturday

10:00 am
— 01:00 pm

Anatomy-
I

06-02-2024

Tuesday

10:00 am
— 01:00 pm

Anatomy-
II

08-02-2024

Thursday

10:00 am
— 01:00 pm

Physiology-
I

10-02-2024

Saturday

10:00 am
— 01:00 pm

Physiology-
II

12-02-2024

Monday

10:00 am
— 01:00 pm

Biochemistry-
I

14-02-2024

Wednesday

10:00 am
— 01:00 pm

Biochemistry-
II

Also Read:AIIMS Nagpur Releases PG Course 1st, 2nd Internal Assessment Exam Timetable

Practical:
– 9:30 am onwards – 

DATE

DAY

DEPARTMENT

15-02-2024

Thursday

ANATOMY

16-02-2024

Friday

PHYSIOLOGY

17-02-2024

Saturday

BIOCHEMISTRY

The list of
eligible candidates for the examination will be published tentatively on
18-01-2024 by the Academic Section. The candidates are directed to ensure that there are no dues in all departments, including the library, mess, etc.

Final
Notification of the examination process will be published on 20-01-2024. The
eligible candidates must submit the requisite examination fee of Rs. 1000/-,
till up examination form & admit card form from 27-01-2024 to 3 0-01-2024.

Only those
eligible students who have paid their examination fees in the account of AIIMS,
Deoghar, will be able to obtain their Hall Ticket/ Admit Card w.e.f. 31-01-202.4
onwards from the office of the undersigned/Exam Cell.

AIIMS Deoghar is a prestigious medical
university and hospital located in Deoghar, Jharkhand, India. It started
operation in 2019. The Institute operates autonomously under the Ministry of
Health and Family Welfare of the Government of India under the Pradhan Mantri
Swasthya Suraksha Yojna (PMSSY) and also among the Institutes of National
Importance in India.

To view the
notice, click on the link below –

https://medicaldialogues.in/pdf_upload/importantnoticeanddatesheetof1stprofmbbssupplementaryexam2022batch29122023050639160-229073.pdf

Also Read:AIIMS Kalyani Releases List Of Provisionally Ineligible Candidates For Externship Program

Powered by WPeMatico

Boston Scientific begins trial to evaluate Farapulse Pulsed Field Ablation System for Persistent Atrial Fibrillation

Marlborough: Boston Scientific Corporation has initiated the AVANT GUARD clinical trial to evaluate the safety and effectiveness of the FARAPULSE Pulsed Field Ablation (PFA) System* as a first-line treatment for persistent atrial fibrillation (AF).

Outcomes of ablation with the FARAPULSE PFA System – a nonthermal treatment in which electric fields selectively ablate heart tissue – will be compared to outcomes following use of anti-arrhythmic drug (AAD) therapy, which is commonly prescribed for patients living with persistent AF.

Unlike paroxysmal AF, which describes symptoms that last for seven days or fewer, persistent AF is a sustained arrhythmia that lasts for more than a week. Early treatment of persistent AF can reduce the risk of blood clots, stroke, and heart failure, and may prevent the disease from becoming permanent. Patients are often treated with AADs as frontline therapy for heart rhythm maintenance, though some can experience adverse effects and limited efficacy. Cardiac ablation is a potential alternative interventional strategy for those living with persistent AF.

“With nearly 40,000 patients treated to date in clinical and commercial settings, the FARAPULSE PFA System continues to demonstrate a promising safety and effectiveness profile, upon which this study seeks to build,” said Dr. Brad Sutton, chief medical officer, AF Solutions, Boston Scientific. “The AVANT GUARD trial is exciting in that it has the potential to change clinical practice by advancing the therapy to be utilized as an earlier treatment for persistent AF, which may lead to better long-term outcomes and establish the FARAPULSE PFA System as the preferred method for treating the disease.”

The randomized AVANT GUARD trial will enroll more than 500 patients diagnosed with persistent AF at up to 75 sites globally. Patients in the study will be randomized to undergo pulmonary vein isolation (PVI) and left atrial posterior wall ablation using the FARAPULSE PFA System, or receive AAD treatment, and followed for three years. The trial will evaluate the outcomes of therapy provided with the FARAPULSE PFA System versus AADs, including device-or procedure-related adverse events, the rates of freedom from AF, atrial flutter, or atrial tachycardia, as well as AF burden – a measurement of the amount of AF an individual experiences.

All patients in the trial will also be inserted with the Boston Scientific LUX-Dx Insertable Cardiac Monitor. This device simplifies the monitoring process for patients by automatically capturing and transmitting arrhythmia episode data, and is designed to detect recurrence of cardiac arrhythmias and assess AF burden by providing continuous rhythm monitoring.

This week, the Cleveland Clinic enrolled the first patient in the AVANT GUARD trial, overseen by Dr. Oussama Wazni, vice chair of cardiovascular medicine and section head, Cardiac Electrophysiology and Pacing, Cleveland Clinic, who is also serving as the lead investigator of the trial.

Earlier this year, clinical trial data presented demonstrated the FARAPULSE PFA System is noninferior to standard-of-care therapies for the treatment of paroxysmal AF, with superior efficiency, while additional real-world data from more than 17,000 patients demonstrated continued real-world safety, efficacy and efficiency of the system. Boston Scientific also completed enrollment in the first phase of the ADVANTAGE AF clinical trial in the third quarter of 2023, which is studying the system for the treatment of patients with drug refractory symptomatic persistent AF, and commenced enrollment in an extension arm of the study to evaluate the safety and effectiveness of adjunctive use of the FARAPOINT PFA Catheter for cavotricuspid isthmus (CTI) ablations, a procedure used to treat atrial flutter.

The company now anticipates U.S. Food and Drug Administration approval of the FARAPULSE PFA System in the first quarter of 2024.

*Caution: Investigational Device. Limited by Federal (or US) law to investigational use only. Not available for sale.

Read also: Boston Scientific to acquire Relievant Medsystems

Powered by WPeMatico

Indian-origin doctor’s pandemic rock band gains popularity, has upcoming tour

London: An Indian-origin doctor with the UK’s state-funded National Health Service (NHS) decided to get musical over the COVID-19 pandemic lockdown, but what started as a one-man bedroom project has been gaining popularity with booked-out shows. 

Gulzar (Gulz) Singh Dhanoya, 25, started the indie-rock band named Gulz during his university days as a medical student. Now the lead vocalist and songwriter of the group has a four-member group made up of fellow NHS medical professionals. 

Also Read:Music training may improve attention and working memory in children: Study

“It was a lot easier when I was at university. I had a lot more time,” Gulz told the BBC Asian Network this week.

“I decided to release some stuff I’d been working on (over the pandemic). I was really nervous and I put it out on socials, then deleted it all off my phone for a week. I was worried my mates were going to give me stick for it. Luckily, it went pretty well,” he said.

Once some of his tracks got picked up by local radio stations, Gulz started getting offers to perform gigs. He then recruited friends from University College London (UCL) who went on to perform at sold-out shows all over London and now have a tour planned for 2024.

“It’s loud. It’s pop. It’s rough-round-the-edges. But it’s sweet,” reads their website.

Describing themselves as “doctors/rockers”, the band recently released their debut EP ‘Age of Youth’ with Fierce Panda Records – a label associated with some of the UK’s biggest bands such as Coldplay and Oasis. Working around their busy medical schedules is not easy but they are committed to making it work.

“We understand that the hospital patients always come first and the need to be a bit flexible with our rehearsals. Like one week, I’ll be on the night shift and then the next week someone else will. We can support each other a bit with that. And on days off, we just focus on the music,” he said.

He admits things do get stressful amid managing hospital rotas, but the music ultimately helps.

“Every time I play a gig – and it sounds really clichéd – I absolutely love it and it reminds me why I do it. There’s this buzz I get. We sacrifice a lot to do this, but it’s worth it,” he added.

He also supports the ongoing NHS junior doctors’ strike, which has been fighting for better pay and working conditions for many months now in pursuit of a better deal with the government.

“Neither industry is amazing for pay,” he notes.

Also Read:’New England Journal of Medicine’ Editor, Dr Rubin and Dr Jitendra Singh discuss future of medical research

Powered by WPeMatico

JIPMER Announces Conduction Of 9th CNE Workshop Based On Short Term Courses For Nurses

Puducherry: Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER) has announced the conduction of the 9th CNE Workshop Based Short Term Course on Research Methodology & Publication for Nurses.

As per the notice, the CNE Workshop will be conducted from 29.01.2024 to 04.02.2024 at Multipurpose Hall, College of Nursing, JIPMER. The Workshop is funded by the Ministry of Health & Family Welfare, Government of India and organized by the College of Nursing, JIPMER, Puducherry. The Tamil Nadu Nurses & Midwives Council, Chennai will award credit hours.

Only 30 participants can participate. Registration confirmation is based on a First come, first served basis. No registration fee is to be paid. The link for registration is enclosed in the notice below. The participants will have to fill out a Google form. TA Rs.500 for 7 days with the submission of documents and whichever is minimum, DA Rs.300/day, Lunch and refreshments will be arranged as per MOHFW (Nursing section) norms. Accommodation needs to be arranged by the participants.

Also Read:Laurels to Dept of nursing Services of JIPMER at SINNCON 2023

The detailed schedule related to the Workshop –

Day 1 – 29.01.2024 – Monday – 

Time

Session

Duration

Resource person/ Guest Speaker

09.00 a.m. – 09.30 a.m.

Registration & Pretest

30 min

Dr. M. J. Kumari

09.30
a.m. –

09.45
a.m.

Inauguration

15 min

–

09.45 a.m. – 10.15 a.m.

Overview of
nursing research –

How to
choose the research problem Steps for formulating research problems
Discussion using examples

30 min

Mr. R. S. Ramesh

10.15
a.m. –

10.30
a.m.

Tea break

15 min

–

10.30
a.m. –

11.15
p.m.

How to
frame the research question, objective Group activity with exercises &
presentation

45 min

Mrs. Vembu.K

11.15
p.m. –

12.00
p.m.

How to
frame the hypothesis and assumption Group activity with exercises &
presentation

45 min

Mrs. Yamuna. T.V.

12.00 p.m. – 01.00 p.m.

Variables
and different types of variables Group activity with discussion

60 min

Dr.KT.Harichandra
kumar

01.00 p.m. – 02.00 p.m.

Lunch break

60 min

–

02.00 p.m. – 02.45 p.m.

How to
search the review of literature, Boolean Operators, Filtering, MESH terms
with demo

45 min

Mrs.
Gomathi Arumugam

02.45 p.m. – 03.30 p.m.

Observational,
descriptive & analytical study Group activity with exercises &
presentation

45 min

Dr. Jeeva
Subramaniam

03.30 p.m. – 04.30 p.m.

COHORT and
Case Control study Group activity with exercises & presentation

60 min

Dr. Sonali Sarkar

Day 2 – 30.01.2024 – Tuesday – 

Time

Session

Duration

Resource person/ Guest Speaker

09.00 a.m. – 10.00 a.m.

Experimental
research design and Randomized controlled trial (RCT) registration with demo
Group activity with exercises & presentation

60 min

Dr. Lakshmi
Ramamoorthy

10.00
a.m. –

11.00
a.m.

Quasi
experimental study with case scenario discussion

60 min

Dr. Jeeva
Subramaniam

11.00
a.m. –

11.15
a.m.

Tea break

15 min

–

11.15
a.m. –

12.15
p.m.

Qualitative studies

Group activity with exercises &
presentation

60 min

Mrs.
Gomathi Arumugam

12.15 p.m. – 01.15 p.m.

Mixed
method research design – Sequential Explanatory, Exploratory &
Transformative Design, Discussion with scenario

60 min

Dr. Porkodi
Rabindran

01.15 p.m. – 02.15 p.m.

Lunch break

60 min

–

02.15 p.m. – 03.15 p.m.

Mixed
method research design – Concurrent Triangulation, Embedded & Transformative
Design, Discussion with scenario

60 min

Mrs. Aruna. P

03.15 p.m. – 04.30 p.m.

Probability
& Non probability sampling technique with exercise, Group activity

75 min

Dr. Jayalakshmy R

Day 3 – 31.01.2024 – Wednesday – 

Time

Session

Duration

Resource person/ Guest Speaker

09.00 a.m.
– 10.00 a.m.

Data,
data types and data summarization

60 min

Dr. G. Prabavathy

10.00 a.m. –

11.00 a.m.

Tabular
and graphical representation of data

60 min

Mrs. R. Anusuya

11.00 a.m. –

11.15 a.m.

Tea break

15 min

–

11.15 a.m. –

12.15 p.m.

Steps in developing questionnaire/ interview schedule

Group activity with exercises

60 min

Dr. Jeeva
Subramaniam

12.15 p.m.
– 01.15 p.m.

Steps in developing observation schedule/ checklist

How to check the reliability & validity of the tool
Group activity with exercises

60 min

Dr. Mahalakshmy T

01.15 p.m.
– 02.15 p.m.

Lunch
break

60 min

–

02.15 p.m.
– 03.15 p.m.

Administration of tool to the study participants –
Discussion with example

60 min

Mrs.
Gomathi Arumugam

03.15 p.m.
– 04.30 p.m.

Techniques of data collection with case scenario discussion

75 min

Dr. Malarvizhi.S

Day 4 – 01.02.2024 – Thursday – 

Time

Session

Duration

Resource person/ Guest Speaker

09.00 a.m. – 10.15 a.m.

Data
collection interview method with role play

75 min

Dr. Selvambigai. V.R

10.15
a.m. –

11.30
a.m.

Research
Bias and how to control the bias Study based discussion

75 min

Ms.H.T.Lalthanthuami

11.30
a.m. –

11.45
a.m.

Tea break

15 min

–

11.45 a.m. – 01.00 p.m.

Introduction
to ethics in human studies ICMR guidelines for responsible conduct of
research

75 min

Dr. Rema Devi

01.00 p.m. – 02.00 p.m.

Lunch break

60 min

–

02.00 p.m. – 03.15 p.m.

IEC members
& IEC committee responsibilities

75 min

Dr. Rajeswari. R

03.15 p.m. – 04.30 p.m.

Level of
risk for human studies with case scenario discussion

75 min

Mrs. Kanimozhi. K

Day 5 – 02.02.2024 – Friday – 

Time

Session

Duration

Resource person/ Guest Speaker

09.00 a.m. – 10.00 a.m.

Health
research on vulnerable population with case scenario discussion

60 min

Dr. Janarthanan.B

10.00
a.m. –

11.00
a.m.

Different
types of Informed consent and patient information

60 min

Dr. K. Sivasankari

11.00
a.m. –

11.15
a.m.

Tea break

15 min

–

11.15
a.m. –

12.15
p.m.

Informed consent for special/ vulnerable
group

60 min

Dr. Vetriselvi. P

12.15 p.m. – 01.15 p.m.

Conflict of
interest with case scenario discussion

60 min

Mrs. Vembu. K

01.15 p.m. – 02.15 p.m.

Lunch break

60 min

–

02.15 p.m. – 03.15 p.m.

Grant
writing for intramural and extramural fund with various source of funding

60 min

Dr. S.
Suresh Kumar

03.15 p.m. – 04.30 p.m.

Checking plagiarism &

Grammar check with demo

75 min

Dr. Noyal
Mariya Joseph

Day 6 – 03.02.2024 – Saturday – 

Time

Session

Duration

Resource person/ Guest Speaker

09.00 a.m. – 10.00 a.m.

Introduction to statistical
inference

60 min

Dr KT.
Harichandra Kumar

10.00
a.m. –

11.00
a.m.

Sample size for descriptive studies

60 min

Dr. G. Prabavathy

11.00
a.m. –

11.15
a.m.

Tea break

15 min

–

11.15
a.m. –

12.15
p.m.

Sample size for analytical studies

60 min

Dr.
KT.Harichandra Kumar

12.15 p.m. – 01.15 p.m.

Publication ethics with case
scenario discussion

60 min

Dr.
Nivethitha Kandasamy

01.15 p.m. – 02.15 p.m.

Lunch break

60 min

–

02.15 p.m. – 03.15 p.m.

Research manuscript
writing for scientific paper publication with group discussion

60 min

Dr. M. J. Kumari

03.15 p.m. – 04.30 p.m.

How to
choose the journal for publication to increase the visibility of publication
with group discussion

75 min

Dr. Subitha.L

Day 7 – 04.02.2024 – Sunday – 

Time

Session

Duration

Resource person/ Guest Speaker

09.00 a.m. – 10.15 a.m.

Different tests of statistical
significance

75 min

Dr. KT
Harichandra Kumar

10.15
a.m. –

11.00
a.m.

How to
prepare the manuscript for poster and oral presentation in conference
discussion with example

45 min

Mrs. Vidya. J

11.00
a.m. –

11.15
a.m.

Tea break

15 min

–

11.15
a.m. –

12.15
p.m.

How to
implement the research findings and practice with case based discussion

60 min

Dr. Kavitha. R.R

12.15 p.m. – 01.15 p.m.

How to
write the research protocol and reference with Demo

60 min

Mrs. S. Rani

01.15 p.m. – 02.15 p.m.

Lunch break

60 min

–

02.15 p.m. – 03.15 p.m.

How to
write the various source of reference Group activity and presentation

60 min

Mrs. S. Rani

03.15 p.m. – 04.30 p.m.

Posttest and valedictory

75 min

Dr. M. J. Kumari

To view the notice, click on the link below –

https://medicaldialogues.in/pdf_upload/brochure-27122023-229067.pdf

Also Read:JIPMER Announces Conduction Of 1st Year Orientation Program For MD, MS, DM, MCH, MDS students

Powered by WPeMatico

Smoking affects brain volume finds a new study

Smoking among the young has increased drastically among the younger population and this habit is often related to lung and heart problems but its association with brain was not well known.

Several studies have shown that brain volume is negatively associated with cigarette smoking, but there is an ongoing debate about whether smoking causes lowered brain volume or a lower brain volume is a risk factor for smoking.

A study carried out by scientists at the University of Washington, United States, showed that smoking also affects the brain, being related to the appearance of Alzheimer’s and dementia, a specialized magazine published. 

Researchers looked at the consequences of tobacco use at the brain level, and their findings help explain why smokers are at high risk of age-related cognitive decline and Alzheimer’s disease, according to an article in Biological Psychiatry: Global Open Science. A history of daily smoking is strongly associated with a decreased total brain volume.

With the aim of unraveling the relationship between genetics, brain and behavior, the authors of the research analyzed data extracted from the UK Biobank, on the health and behavior of half a million people, mostly of European descent.

The team analyzed de-identified data on brain volume, smoking history and genetic risk of smoking from 32,094 people.

They were able to show that each pair of factors were related: smoking history and brain volume; genetic risk of smoking and history of smoking; and genetic risk of smoking and brain volume. Furthermore, the association between smoking and brain volume was dose-dependent: the more packs a person smoked per day, the smaller their brain volume.

When all three factors were considered together, the association between genetic risk for smoking and brain volume disappeared, while the link between each of them and smoking behaviors remained.

Using a statistical approach known as mediation analysis, the researchers determined the sequence of events: genetic predisposition leads to smoking, which leads to a decrease in brain volume.

Reference: Yoonhoo Chang, Vera Thornton, Ariya Chaloemtoem et al; Investigating the Relationship Between Smoking Behavior and Global Brain Volume; Biological Psychiatry: Global Open Science, | VOLUME 4, ISSUE 1, P74-82, JANUARY 2024.

Powered by WPeMatico

MUHS to hold its 23rd Convocation Ceremony in February, all details here

Maharashtra: The 23rd convocation ceremony of Maharashtra University of Health Sciences (MUHS) is going to be held on 23rd February 2023 for various UG and PG courses.

The candidates will have to fill out the application form for the ceremony. Printed application forms will not be available offline. Eligible candidates will have to download the application form and take a printout of it. The application form is enclosed in the notice below. Application, duly completed in all respects, should reach the Controller of Examinations on or before 05.01.2024. If the application form is received after this date, the Degree Certificate / Diploma Certificate will be issued after the Convocation Ceremony as per due procedure.

It is further informed that those candidates who fail to submit their application within the stipulated time period and applications received at a later date will attract late fee charges mentioned in the University Circular dated 21.03.2014.

Also Read:CPS announces Convocation Ceremony For Diploma, FCPS Students

Successful candidates of the following courses will be awarded the degree certificates/certificates in this convocation ceremony –

Course

Batch and Year

MBBS

Summer 2022

BDS

Summer 2022

BAMS

Summer 2022

BUMS

Summer 2022

BHMS

Summer 2022

Basic BSc (Nursing)

Summer 2023

PBBSc (Nursing)

Summer 2023

BSc in Paramedical Technology

Summer 2022

MD (Medical)

Summer 2023 & Winter 2023

MS (Medical)

Summer 2023 & Winter 2023

DM (Medical)

Summer 2023 & Winter 2023

MCh (Medical)

Summer 2023 8v Winter 2023

MSc (Medical Biochemistry)

Summer 2023 & Winter 2023

PG Diploma (All)

Summer 2023

Diploma in Optometry

Summer 2023

Bachelor of Optometry

Summer 2022

Diploma in Para Medical

Summer 2023

MDS (Dental)

Summer 2023

MD (Ayurveda)

Summer 2023

MS (Ayurveda)

Summer 2023

Course

Batch and Year

MD (Unani)

Summer 2023

MS (Unani)

Summer 2023

MD (Homoeopathy)

Summer 2023

MSc (Nursing)

Summer 2023

MBA

Summer 2023 & Winter 2023

MPH (N)

Summer 2023 & Winter 2023

MPH

Winter 2023

PhD

After the date of Mini Convocation-2023 & results
declared before the date of Convocation

All Certificate / Fellowship Courses

Summer 2023

Students of earlier courses and batches covered during the last,
i.e. 22″d convocation ceremony, can apply only in absentia. Degree
Certificates / Diploma Certificates of all the candidates who opt to receive
their Degree Certificates / Diploma Certificates in absentia will be sent to
their respective colleges. However, students covered under the above-mentioned
courses can apply for receiving the Degree Certificate / Diploma Certificate
either in person or in abseatia. No change in the mode of receipt of Degree
Certificate / Diploma Certificates will be permitted once opted.

To view the notice, click on the link below –

https://medicaldialogues.in/pdf_upload/examcircular-no90convocation-281223-1-229048.pdf

Also Read:WBUHS opens University online registration portal For MSc Nursing, Post Basic BSc Nursing Courses

Powered by WPeMatico

WBCERC has no authority to adjudicate medical negligence cases: Calcutta HC

In a major decision, the Calcutta High Court bench has clearly iterated that matters concerning the issues of medical negligence cannot be adjudicated by the West Bengal Clinical Establishment Regulatory Commission (WBCERC).

Clarifying its stand in this regard, the HC bench comprising Justice Arijit Banerjee and Justice Apurba Sinha Ray noted, “The negligence in detection of diseases and the allegation of not giving proper medicines to the patient and further improper diagnosis of the diseases are all matters or issues of medical negligence. Therefore, the said issues cannot be adjudicated by the Commission.”

For more details, check out the link given below:

WBCERC Has No Authority To Adjudicate Medical Negligence Cases: Calcutta High Court

Powered by WPeMatico

Conduct BE study with innovator drug as reference product: CDSCO Panel Tells Synokem on FDC Torsemide plus Eplerenone

New Delhi: After reviewing the bioequivalence (BE) study report presented by Synokem Pharmaceutical for the fixed-dose combination Torsemide IP 10mg/20mg plus Eplerenone IP 25mg/25mg film-coated tablet, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has recommended that the firm should conduct BE study with individual innovator drugs as a reference product and submit the BE protocol to the committee.

This came after Synokem Pharmaceutical presented its proposal and a BE study report before the committee.

The committee noted that the firm has not conducted the BE study with individual innovator drugs as a reference product.

Torsemide belongs to the group of medicines called loop diuretics (water pills). This medicine works by acting on the kidneys to increase the flow of urine. Torsemide is used to help treat fluid retention (edema) and swelling that is caused by congestive heart failure, liver disease, and kidney disease. It belongs to the group of medicines called loop diuretics (water pills). This medicine works by acting on the kidneys to increase the flow of urine.

Eplerenone belongs to the general class of medicines called antihypertensives. It is used alone or with other medicines to treat high blood pressure (hypertension). This medicine is also used to treat congestive heart failure (CHF) after a heart attack.

Eplerenone selectively binds to the mineralocorticoid receptor, thereby blocking the binding of aldosterone and thus inhibiting sodium reabsorption and other deleterious aldosterone-mediated mechanisms.

At the SEC meeting for Cardiovascular and Renal held on 22nd November 2023, the expert panel reviewed the proposal presented by the drug major Synokem Pharmaceutical along with the BE study report of the FDC Torsemide plus Eplerenone film coated table.

The committee took note of the fact that the company had not used specific innovative medications as a reference product in the BE study.

After detailed deliberation, the committee recommended that the firm should conduct a BE study with individual innovator drugs as a reference product.

Accordingly, the expert panel suggested that the firm should submit the BE protocol to CDSCO for further review.

Also Read:Include Ankle Brachial Index test to exclude peripheral artery disease: CDSCO Panel Tells Lupin on Denosumab PK/PD study

Powered by WPeMatico

Amendments to MTP Act soon: Delhi LG VK Saxena

New Delhi: After a two-year delay, the proposal to notify women-friendly amendments in the Medical Termination of Pregnancy (MTP) Act that provides for universal access for women to comprehensive abortion care has been approved by Lieutenant Governor V K Saxena.

LG V K Saxena has directed the health department to investigate the lapses that led to delays in the processing of the matter.

Delhi will soon notify women-friendly amendments to the Medical Termination of Pregnancy Act, with Lieutenant Governor V K Saxena approving the city government’s proposal in this regard, Raj Niwas officials said on Thursday.  

However, Saxena expressed “grave displeasure” and “surprise” that the matter was presented for approval after a lapse of more than two years, they added.

Also Read:U Turn: SC recalls Order calling for MTP at 26 weeks

“The LG has approved the proposal of the Delhi government’s Department of Health and Family Welfare for issuance of notification regarding the statutory forms under the Medical Termination of Pregnancy (Amendment) Act, 2021 that provide for universal access for women to comprehensive abortion care and termination of certain pregnancies by registered medical practitioners (RMPs),” an official said.

The communication for notifying the Act was mailed by the Centre to the Delhi government in December 2021, he added.

Saxena directed the health department to ascertain the lapses leading to the “inordinate delay” in processing the matter and asked to assign the responsibility and exercise caution in the future, the official said.

The Act was amended by the Centre in 2021, after which the opinion of only one RMP is required up to 20 weeks of gestation and of two RMPs to terminate pregnancy of 20-24 weeks of gestation under special circumstances. The amended Act provided for the constitution of a medical board for granting permission to terminate pregnancy beyond 24 weeks under circumstances to be decided by it.

The Ministry of Health and Family Welfare conveyed in 2021 that the forms for the documentation of medical termination of pregnancy (which were earlier issued in terms of the MTP Act, 1971) were updated in consonance with the Medical Termination of Pregnancy (Amendment) Act and Rules, 2021.

The ministry had directed the states and Union territories to notify Forms 1, 2 and 3 in the official gazette under the MTP Regulations, the official explained.

The amendments carried out in Form 1 (RMP Opinion Form) require the name, qualifications and address of only one RMP and the words “married woman” have been replaced with “woman” and the word “husband” has been replaced with “partner”.

In Form 2, which stipulates the regulations, three additional sub-heads regarding the duration of pregnancy have been added, and the reasons for termination of pregnancy have been divided into A, B and C categories, depending on the number of weeks of gestation.

Form 3 concerns the admission register in which a phrase has been added for pregnancy beyond 24 weeks and which says that the names of the medical board members have to be mentioned.

The LG was informed that the Department of Health and Family Welfare’s proposal regarding the notification of the statutory forms has been endorsed by the health minister and approved by the chief minister.

Also Read:Delhi HC directs LNJP Hospital to examine pregnant woman seeking termination of 33-week fetus

Powered by WPeMatico